Dr Reddy's Laboratories LtdAdd to My Watchlist

RDY:USNew YorkIndustry: Medical-Drugs
  • 36.68
  • 0.37  1.02%
    Today's Change
  • 36.31
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 10/20/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding166 million
Market Cap$6 billion
Return on Equity ttm9.64%
Last Dividend$0.29
Dividend Yield ttm0.86
Relative Dividend Yield benchmark--
Dividend Ex-Date7/13/17
Dividend Pay Date8/10/17
EPS: Year Actual ttm--
EPS: Year Est. 3/18 ttm110.648
EPS: Quarterly Actual -- --
EPS: Quarterly Est. -- --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-42.18
Company Description
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
Revenue$141 billion
Net Income$12 billion
Total Assets$220 billion
Web Sitewww.drreddys.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!